STOCK TITAN

GrafTech International Ltd. 10-Q Filings

EAF NYSE

Every 10-Q that GrafTech International Ltd. (EAF) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-Q covers the quarterly report filed between annual reports, so if you follow EAF and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full EAF filings page.

Rhea-AI Summary

GrafTech International reported second‑quarter 2026 results with net sales of $127.4 million, down 3% year over year, and a net loss of $40.5 million, which narrowed from $86.9 million a year earlier. Diluted loss per share improved to $1.54 from $3.35.

Sales volume rose to 30.8 thousand metric tons, up 8%, while the weighted‑average realized price declined 7% to about $3,900 per MT amid competitive pressure. Capacity utilization increased to 74% from 65%, cash cost of goods sold per ton fell 6%, and a $12.3 million gain on landfill asset sales boosted other income.

As of June 30, 2026, GrafTech had liquidity of $253.0 million, including $145.4 million of cash and $107.6 million of revolver availability, against approximately $1.2 billion of total debt and a stockholders’ deficit of $345.6 million. Management expects 2026 graphite electrode sales volumes to rise 5–10%, a low single‑digit percentage‑point decline in cash cost of goods sold per ton, and capital expenditures of about $35 million, supported by more than 90% of anticipated volume already committed and recent contracts priced over 15% above comparable first‑quarter commitments.

Rhea-AI Summary

GrafTech International Ltd. reported a larger net loss for the quarter ended March 31, 2026 despite higher sales. Net sales rose to $125.1 million from $111.8 million as graphite electrode sales volume increased 14% to 28.1 thousand metric tons, but the weighted‑average realized price fell about 5% to roughly $3,900 per MT.

Higher costs and inventory valuation charges drove a gross loss of $15.0 million and an operating loss of $30.7 million. Net loss widened to $43.3 million, or $(1.66) per share. Cash used in operating activities improved to $14.9 million, aided by working capital, while capital expenditures were $12.1 million.

GrafTech ended the quarter with $328.7 million of liquidity, including $120.2 million of cash and $209 million of available credit facilities, against $1.1 billion of long‑term debt and a stockholders’ deficit of $304.4 million. Management expects 2026 graphite electrode sales volume to rise 5–10%, modest cost improvements per ton, and capital expenditures of about $35 million while pursuing price increases and cost actions to restore profitability.

Rhea-AI Summary

GrafTech International (EAF) reported Q3 2025 results with net sales of $143.998 million and a net loss of $28.482 million. Gross profit was $10.307 million as cost controls and lower inventory charges offset pricing pressure.

The company completed a 1-for-10 reverse stock split on August 29, 2025 to maintain NYSE compliance. As of October 17, 2025, 25,820,110 shares were outstanding. Liquidity totaled $384.3 million, including cash of $177.6 million, $106.7 million of revolver availability, and $100.0 million of delayed-draw term loan availability; total long-term debt was $1.093 billion.

Sales volume rose to 28.8 thousand MT, while the weighted-average realized price was approximately $4,200 per MT. Management now expects an 8–10% year-over-year sales volume increase for 2025 and about a 10% decline in cash cost of goods sold per MT, and continues to target capital expenditures of approximately $40 million for the year.

Rhea-AI Summary

GrafTech International (EAF) Q2-25 10-Q highlights

  • Net sales fell 4% YoY to $131.8 m as average graphite-electrode price dropped 12% to ≈$4,200/MT; volume rose 12% to 28.6 k MT.
  • Profitability: gross profit was nearly breakeven ($0.1 m) vs $4.0 m prior-year; operating loss widened to $14.6 m; a $42.6 m valuation allowance drove income-tax expense of $51.2 m, pushing net loss to $86.9 m (-$0.34/sh) vs -$14.8 m (-$0.06/sh).
  • YTD net sales down 11% to $243.7 m; net loss $126.2 m. Cash used in operations was $85.4 m vs $37.4 m.
  • Balance sheet: cash = $158.5 m (-$97.7 m YTD); long-term debt $1.09 bn; available liquidity $366.5 m (incl. $208 m undrawn credit/term facilities). Net debt ≈$0.93 bn; interest expense up 63% to $25.4 m for the quarter.
  • Costs: cash COGS/MT guided to fall 7-9% FY-25; LCM inventory charges $1.9 m in Q2.
  • Outlook: management expects FY-25 sales volume to rise ~10% YoY, targeting breakeven adjusted EBITDA in 2H-25; announced 15% list-price increase on un-committed 2025 volumes.
  • Covenants: company states compliance with all debt covenants; TRA liability fully written off after allowance.

Key concerns: sustained price pressure outside U.S., high leverage, significant cash burn, and large deferred-tax valuation allowance signal near-term earnings headwinds.